View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
January 6, 2022

Seger starts development of intracorporeal anastomosis laparoscopic device

LAP IA 60 aligns, closes and staples the common opening for intracorporeal anastomosis quickly and securely.

By Hasini Devarasetti

Seger Surgical Solutions has commenced the development of its next-generation laparoscopic bowel closure device for intracorporeal anastomosis.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

The new device, named LAP IA 60, is capable of aligning, closing and stapling the common opening for intracorporeal anastomosis quickly, securely and without the need for suturing.

Compared to suturing, which takes roughly 15 to 20 minutes, the Seger device closes the enterotomy in less than two minutes.

In a statement, Seger said: “Extracorporeal anastomosis has been shown to result in longer hospital stays and increased hospitalisation costs due to post-operative complications, including higher post-op hernia rates with midline incisions, increased pain and worse cosmesis due to larger incisions.”

Inserted through a standard 12-millimetre trocar, the closure device allows surgeons to perform complete laparoscopic bowel anastomoses for improved clinical results.

This also provides better outcomes, improves patient care and reduces complications as well as healthcare costs.

Bowel resection surgery involves the removal of a part of the intestine followed by the surgeon creating a common opening (enterotomy) in the two bowel sections for connecting them (anastomosis).

Due to challenges presented by laparoscopic suturing, most resections and anastomoses are now performed outside the abdomen (extracorporeal).

Last October, Medtronic obtained CE mark for its Hugo robotic-assisted surgery (RAS) system to be used in procedures related to urology and gynaecology.

It comes with a Cloud-based surgical video recording option that is enabled through the Touch Surgery Enterprise.

Commercially available in Europe, the Hugo RAS system was designed to address the cost and utilisation barriers that have restricted the adoption of robotic surgery for the last 20 years.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network